Skip to content

H.R. 1561 · 119th Congress (2025–2027)

ALERT Communities Act

This bill establishes programs and requirements to advance the development and usage of test strips that detect the presence of certain hazardous drugs (e.g., fentanyl, xylazine).

Currently, the Substance Abuse and Mental Health Services Administration provides grants to government entities to train and provide authorized equipment to first responders and other relevant personnel for emergency treatment of opioid overdoses. The bill expands these grants to include rapid response test strips for detecting the presence of fentanyl, xylazine, and other synthetic opioids or emerging substances in people or within other drugs.

Additionally, the bill requires the Department of Health and Human Services (HHS) to publish guidance and standards for test strip manufacturers to support the development, evaluation, and authorization of test strips.

Also, HHS must conduct a study and report to Congress on how the availability and usage of test strips and similar equipment impacts the frequency of overdoses and participation in substance use disorder treatment.

Show official title

To require research with respect to fentanyl and xylazine test strips, to authorize the use of grant funds for such test strips, and for other purposes.

Ordered to be reported

Latest actionOrdered reported

This bill’s path

This is H.R. 1561’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Jasmine Crockett (D-TX-30)
Cosponsors
1 cosponsor

1 original · 0 later

  1. Rep. Lance Gooden (R-TX-5)· Original · Feb 25, 2025
Policy area
Health
Subjects
  • Congressional oversight
  • Drug trafficking and controlled substances
  • First responders and emergency personnel
  • Government studies and investigations
  • Medical research
  • Medical tests and diagnostic methods
  • Research administration and funding

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Referred to Health

    Referred to the Subcommittee on Health.

    Sources
  2. Introduced in House

    Document: Introduced in House

    Sources
  3. Latest
    ▸ 6 committee actions · Feb 25, 2025 – Jul 21, 2026
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Subcommittee markup session held

      Subcommittee Consideration and Mark-up Session Held

      Sources
    3. Forwarded by subcommittee

      Forwarded by Subcommittee to Full Committee by Voice Vote.

      Sources
    4. Markup session held

      Committee Consideration and Mark-up Session Held

      Sources
    5. Markup session held

      Committee Consideration and Mark-up Session Held

      Sources
    6. Ordered reported

      Ordered to be Reported by the Yeas and Nays: 48 - 0.

      Sources

Committees

  1. HouseEnergy and CommerceReferred Feb 25, 2025 · Markup Jul 20, 2026 · Markup Jul 21, 2026
    1. Jul 20, 2026 · Markup

  2. HouseHealthReferred Feb 25, 2025 · Markup Jun 25, 2026 · Reported Jun 25, 2026
    1. Jun 25, 2026 · Markup

    2. Mar 26, 2026 · Hearing

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. ALERT Communities Act

    Display title, Short title · Introduced in House

  2. Advancing Lifesaving Efforts with Rapid Test strips for Communities Act

    Short title · Introduced in House

  3. To require research with respect to fentanyl and xylazine test strips, to authorize the use of grant funds for such test strips, and for other purposes.

    Official title · Introduced in House